Please provide your email address to receive an email when new articles are posted on . This two-part series will review innovative sustained-delivery options in the retina space for both long- and ...

There has been dramatic growth in the number of intravitreal injections performed annually. This paper features expert panel consensus regarding the use of intravitreal injections and serves as an ...

Please provide your email address to receive an email when new articles are posted on . In the past decade, intravitreal injections have transformed the way that we treat retinal disease, particularly ...

An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...

April 28, 2005 — The U.S. Food and Drug Administration (FDA) has approved fluocinolone acetonide 0.59-mg intravitreal implant for the treatment of chronic noninfectious uveitis affecting the posterior ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...